Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with advanced non-small cell lung cancer and for whom a type of targeted treatment called a TKI (tyrosine kinase inhibitor) has been recommended as a first or second treatment option (combining this with chemotherapy is also allowed)
- People who have a stored tissue or cell sample available (collected through a biopsy method known as FFPE or FNA)
- People who are able and willing to follow the treatment plan required by the trial
- People who have given their consent to take part in the study
Who may not be able to join:
- People who have already begun TKI treatment before enrolling in the trial
- People who have already begun chemotherapy before enrolling in the trial
- People whose physical health, mental health, or work responsibilities may make it difficult to follow the trial's treatment plan
- People who have not agreed to participate in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sinh D Nguyen, PhD, MGI
Phone: +84888843489
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Relationship between ctDNA dynamics and clinical response to TKI; To compare and combine ctDNA dynamics and RECIST1.1 to predict clinical response.; To investigate the relationship between ctDNA dynamics and progression free survival, overall survival.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.